Experimental injection plus tirzepatide for weight loss in obesity
Part of Hormones & metabolism clinical trials.
This study tests an experimental medicine (LAE102) combined with a known weight-loss drug (tirzepatide) to see if it helps people with obesity lose more weight safely. You would receive the study drug or a placebo (a dummy shot), and the goal is to find a better way to manage weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your BMI (a measure of body fat) is between 28 and 40.
- You have tried diet and exercise to lose weight but have not been able to reach your goal (for example, you lost less than 5% of your body weight in the past 3 months with diet and exercise alone).
- You do not have diabetes or high blood sugar that is not well controlled.
- You have not had weight-loss surgery (like gastric bypass or a gastric balloon) before, and you are not planning to have it during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, NA-931, combined with an existing weight-loss medication (tirzepatide) to see if they work well and are safe for adults who are overweight or obese. It may help you lose weight and improve health conditions related to excess weight.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This trial tests an experimental drug called RN3161 to see if it helps with weight loss in people with overweight or obesity. It can be taken alone or with another weight-loss medication (tirzepatide).
This trial looks at whether a medicine called tirzepatide (given as an injection) helps people with obesity lose weight in real life. Researchers will also see how people use the medicine, which may help doctors find better ways to treat obesity.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This study tests a medication called tirzepatide (a daily injection) to help people who haven't lost enough weight after weight-loss surgery. If you fit the criteria, the medication may help you lose more weight healthily.
Hear when a new Obesity Adult Onset trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.